Expanding the Reach of RNAi Therapeutics with Next Generation Lipophilic siRNA Conjugates
Kirk Brown(Alnylam Pharmaceuticals (United States)), Vasant Jadhav(Alnylam Pharmaceuticals (United States))
Cited by 3
Related Papers
Expanding RNAi therapeutics to extrahepatic tissues with lipophilic conjugates
|Nature Biotechnology|2022|239
Pharmacological Characterization of a Novel ENaCα siRNA (GSK2225745) With Potential for the Treatment of Cystic Fibrosis
|Molecular Therapy — Nucleic Acids|2013|37